Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Leveraging a vendor-neutral deep learning reconstruction algorithm to reduce scan time and enhance image quality in T2-weighted liver MRI.

Created on 09 Jul 2026

Authors

Boryeong Jeong, Seung-Seob Kim

Published in

Scientific reports. Jul 08, 2026. Epub Jul 08, 2026.

Abstract

This study evaluated whether a vendor-neutral deep learning reconstruction (DLR) can improve image quality in accelerated T2-weighted imaging (T2WI) of the liver MRI acquired in a single breath-hold compared with routine T2WI. In this retrospective study, 86 patients who underwent nonenhanced 3-T liver MRI in August 2024 were included. Two board-certified radiologists independently assessed T2WI obtained using three protocols: (1) routine T2WI acquired with two breath-holds (Routine-2BH); (2) accelerated T2WI reconstructed with DLR acquired in a single breath-hold (SwiftMR-1BH); and (3) accelerated T2WI reconstructed with DLR acquired with two breath-holds (SwiftMR-2BH). Quantitative signal-to-noise ratio (SNR) and qualitative image quality, including sharpness, motion artifacts, spatial mismatch, and lesion conspicuity, were evaluated. The SwiftMR protocols reduced acquisition time by approximately 9 s compared with the routine protocol. Compared with Routine-2BH protocol, both SwiftMR protocols showed significantly higher sharpness and SNR (p < 0.001), although motion artifacts were more pronounced. Spatial mismatch scores were significantly lower with SwiftMR-1BH than with Routine-2BH and SwiftMR-2BH (p < 0.05). Among 49 patients with focal liver lesions, lesion conspicuity was generally higher with SwiftMR protocols, although not consistently significant. Overall, vendor-neutral DLR using SwiftMR restored the image quality of accelerated single-breath-hold T2WI for liver MRI, resulting in a higher SNR and overall image quality than routine two-breath-hold T2WI.

PMID:
42420358
Bibliographic data and abstract were imported from PubMed on 09 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement